Using immune cells and MRI to predict return of colorectal cancer in the liver
Part of Cancer, Digestive system clinical trials.
This study looks at your liver tumor's immune cells and MRI images to see if the cancer is likely to come back after surgery. The goal is to better predict recurrence and personalize follow-up care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have colorectal cancer that has spread to your liver (confirmed by biopsy).
- Before your liver surgery, you had chemotherapy and your tumors shrank or stayed the same (not grew).
- You had an MRI with contrast dye within 2 months before your surgery.
- This is your first time the cancer has spread to the liver (not a return).
- You do not have hepatitis B or C, and you have not had another type of cancer treated in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well imaging predicts the outcome of surgery for liver metastases from colorectal or breast cancer. If you are having surgery to remove liver metastases, you may be able to participate.
This trial tests a combination of precise radiation to liver or lung tumors plus immunotherapy for people with advanced colorectal cancer that cannot be surgically removed. It aims to see if this approach can help control the cancer.
This trial tests combinations of immunotherapy drugs for people with colorectal cancer that has spread to the liver and is scheduled for surgery. The goal is to see if these treatments are safe and effective before and after the operation.
This trial studies liver transplantation for certain people with colorectal cancer that has spread only to the liver and cannot be removed with surgery. It aims to improve outcomes for carefully selected patients whose cancer is controlled on chemotherapy and who meet specific safety and scan requirements.
This study looks at whether a combination of clinical factors and genetic tests can better predict early return of cancer in people who had surgery for colorectal cancer that spread to the liver. It may help guide future treatment decisions.
This trial studies how well MRI can evaluate liver metastases (spread to the liver) from colorectal cancer. If you have measurable liver lesions, your MRI results may help doctors better track and plan care.
Hear when a new Colo-rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.